NuVasive Announces $154.4M Revenue for 2Q, Up 16.1%

Spinal Tech

NuVasive, a medical device company focused on minimally disruptive surgical products and procedures for the spine, announced revenue of $154.4 million for the second quarter this year, up 16.1 percent from the same period in 2011. The second quarter revenues also indicate a 1.8 percent increase over the $151.7 million reported for the first quarter 2012. Gross profit for the second quarter 2012 was $117.9 million and gross margin was 76.3 percent, compared to a gross profit of $107.5 million and a gross margin of 80.8 percent for the second quarter last year.

The company also reported higher operating expenses for the second quarter 2012 of $104.9 million compared to $96.0 million in the second quarter last year. The higher operating expenses stemmed from additional costs associated with higher revenue and infrastructure expansion.

More Articles on Orthopedic Devices:

Minimally Invasive Surgery Market to Reach $35.5B by 2016

MiMedx Revenues Reach $4.9M in 2Q, 153% Increase

China Device Market Expected Grew at 20.5% CAGR From 2006-2011

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers